Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History
Sb Investment Advisers (Uk) LTD
- $10.8 Billion
- Q2 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 71,361,388 shares of ROIV stock, worth $819 Million. This represents 6.97% of its overall portfolio holdings.
Number of Shares
71,361,388
Previous 73,031,667
2.29%
Holding current value
$819 Million
Previous $770 Million
2.01%
% of portfolio
6.97%
Previous 7.6%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Viking Global Investors LP69.2MShares$794 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$766 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$406 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$337 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY23MShares$264 Million7.2% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.09B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...